James O. Gesling joined the Food and Drug Administration (FDA) in 1956 , when he graduated from Northwest Missouri State College. Initially, he was an inspector in the FDA Kansas City District. Beginning in 1968, he was assistant director for regulations and administration of the FDA’s Bureau of Veterinary Medicine. He later became the Executive Officer of the Bureau of Veterinary Medicine.
When the National Institutes of Health (NIH) Division of Biologics Standards (DBS) moved to the FDA in 1972, Gesling became the Associate Director for Management and Compliance at what was then called the Bureau of Biologics.
Dive
class
grid-col-4
Span
class
caption
James Gesling
Span
class
credit
FDA Papers July-August 1970
Dive
preface
class
grid-row grid-gap
Dive
class
grid-col-4
Under Gesling, the Bureau of Biologics launched a comprehensive investigation of the nation’s plasma businesses, closing dozens for dangerous practices and passing new regulations to address industry operations that put donors and recipients of plasma products at risk (see newspaper clipping at right). James O. Gesling passed away in 1978.
Info
Gesling worked in Building 29, Room 130.
Dive
class
grid-col-8
Span
class
caption
The FDA's ramping up of activities in regulating blood products to protect donors and recipients attracted much attention (from the St. Petersburg-Tampa Bay Times, Aug 6, 1974).
